Endothelial Facilitation in Alzheimer's Disease. An Open Label Pilot Study of the Sequential and Cumulative Effects of Simvastatin, L-Arginine, and Sapropterin (Kuvan) on Cerebral Blood Flow and Cognitive Function in Patients With Alzheimer's Disease
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 11 Jan 2017
At a glance
- Drugs Arginine (Primary) ; Sapropterin (Primary) ; Simvastatin (Primary)
- Indications Alzheimer's disease
- Focus Pharmacodynamics
- 06 Jan 2017 Status changed from recruiting to active, no longer recruiting.
- 04 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 04 Jan 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.